Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

S. Vaidya, Jayant; Wenz, Frederik; Bulsara, Max; Tobias, Jeffrey; Joseph, David; Keshtgar, Mohammed; Flyger, Henrik; Massarut, Samuele; Alvarado, Michael; Saunders, Christobel; Eiermann, W.; Metaxas, Marinos; Sperk, Elena; Sütterlin, Marc; Brown, Douglas; J. Esserman, Laura; Roncadin, Mario; M. Thompson, Alastair; Dewar, John; Holtveg, Helle; Pigorsch, Steffi; Falzon, Mary; Harris, Eleanor; Matthews, April; Brew‐Graves, Chris; Potyka, Ingrid; Corica, Tammy; Williams, Norman; Baum, Michael

doi:10.1016/s0140-6736(13)61950-9

Public

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Published in The Lancet • Nov 10, 2013

Authors:

Jayant S. Vaidya

Frederik Wenz

Max Bulsara

Abstract

BACKGROUND: The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival. METHODS...

Subject

Medicine

Lumpectomy

Radiation therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!